Morgan J D, Reddy S, Sarin P, Yordan E, DeGeest K, Hendrickson F R
Department of Radiation Oncology, Rush-Presbyterian-St Luke's Medical Center, Chicago, IL 60612.
Radiology. 1993 Nov;189(2):609-13. doi: 10.1148/radiology.189.2.8210396.
The authors undertook this study to evaluate the results of radiation therapy (RT) for vaginal recurrence in early stage endometrial carcinoma.
Between 1964 and 1987, 34 patients with isolated vaginal recurrences of endometrial carcinoma were treated with RT. The records were reviewed for outcome and prognostic factors, such as location of tumor recurrence, time to recurrence, size of tumor at recurrence, tumor differentiation, and total radiation dose delivered at RT.
With a median follow-up of 48 months, the 5-year actuarial survival and disease-free survival rates were 68% +/- 4 and 60% +/- 3, respectively. Results were statistically significant for some prognostic factors, including time to tumor recurrence and total radiation dose delivered at RT to the recurring tumor.
Long-term survival can be obtained for patients with an isolated vaginal recurrence of endometrial cancer treated with aggressive local-regional radiation therapy.
作者开展本研究以评估早期子宫内膜癌阴道复发的放射治疗(RT)效果。
1964年至1987年间,34例孤立性子宫内膜癌阴道复发患者接受了放射治疗。回顾记录以分析结果及预后因素,如肿瘤复发部位、复发时间、复发时肿瘤大小、肿瘤分化程度以及放射治疗时给予的总辐射剂量。
中位随访时间为48个月,5年精算生存率和无病生存率分别为68%±4和60%±3。某些预后因素具有统计学意义,包括肿瘤复发时间以及对复发肿瘤进行放射治疗时给予的总辐射剂量。
对于接受积极局部区域放射治疗的孤立性子宫内膜癌阴道复发患者,可实现长期生存。